secwatch.observer — SEC 8-K summary
======================================

Issuer:     QuidelOrtho Corp (QDEL)
CIK:        0001906324
Form:       8-K
Filed at:   2025-05-07T23:59:59+00:00
Accession:  0001906324-25-000055
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QuidelOrtho Q1 revenue $693M, +5% ex-COVID/Donor; adjusted EPS $0.74 vs $0.44 YoY
--------------------------------------------------------------------------------

- Total revenue $693M, -3% reported due to lower COVID/Donor; ex-COVID/Donor +5% as reported and +6% constant currency.
- GAAP operating margin improved to 5% from (247%); adjusted EBITDA margin 23%, +450 bps driven by cost-savings.
- GAAP diluted loss per share $0.19 vs $25.50 loss prior (which included $1.74B goodwill impairment); adjusted EPS $0.74 vs $0.44.
- Labs revenue grew 5% as reported (7% constant currency); Donor Screening declined 62% as business winds down.
- Full-year 2025 guidance maintained: revenue $2.60-$2.81B, adjusted EBITDA $575-615M, adjusted diluted EPS $2.07-$2.57.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1906324/000190632425000055/0001906324-25-000055-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1906324/000190632425000055/qdel-20250507.htm
  HTML page:      https://secwatch.observer/filing/0001906324-25-000055

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer